Skip Navigation Links
Centers for Disease Control and Prevention
CDC Home Search Health Topics A-Z




DISSS Home | Contact Us
 Health and Human Services Logo



Animated FirstGov Logo - Click to enter FirstGov


Q Fever (Coxiella burnetii)

Contents
Home - National Notifiable Diseases Surveillance System
Overview
Introduction
List of Nationally Notifiable Diseases
Alphabetical List of Case Definitions
Definition of Terms
Related Links
References
  Site Search


1999 Case Definition

Clinical description

Acute infection: A febrile illness usually accompanied by rigors, myalgia, malaise, and retrobulbar headache. Severe disease can include acute hepatitis, pneumonia, and meningoencephalitis. Clinical laboratory findings may include elevated liver enzyme levels and abnormal chest film findings. Asymptomatic infections may also occur.

Chronic infection: Potentially fatal endocarditis may evolve months to years after acute infection, particularly in persons with underlying valvular disease. A chronic fatigue-like syndrome has been reported in some Q fever patients.

Laboratory criteria for diagnosis

  • Fourfold or greater change in antibody titer to C. burnetii phase II or phase I antigen in paired serum specimens ideally taken 3-6 weeks apart, or,
  • Isolation of C. burnetii from a clinical specimen by culture, or
  • Demonstration of C. burnetii in a clinical specimen by detection of antigen or nucleic acid.

Case classification

Probable: a clinically compatible or epidemiologically linked case with a single supportive Immunoglobulin G (IgG) or Immunoglobulin M (IgM) titer. Cutoff titers are determined by individual laboratories. CDC tests for IgG antibodies with an indirect immunofluorescence assay (IFA), and uses a titer of 1:128 as the cutoff for significant antibody.

Confirmed: a clinically compatible or epidemiologically linked case that is laboratory confirmed.

See also:

Printable Version

 


 



Privacy Policy | Accessibility

DISSS Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last updated January 5, 2009

United States Department of Health and Human Services
Centers for Disease Control and Prevention

"Epi Info" is a trademark of the Centers for Disease Control and Prevention (CDC).